At a glance
- Originator Chugai Pharmaceutical
- Class Aminobenzoic acids; Antiallergics; Benzamides; Muscle relaxants; Small molecules
- Mechanism of Action Mast cell stabilisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 13 Aug 1997 Discontinued-III for Asthma in Japan (PO)